First Chemical Investigation of Korean Wild Mushroom, <i>Amanita hemibapha</i> subsp. <i>javanica</i> and the Identification of Anti-<i>Helicobacter pylori</i> Compounds

<i>Amanita hemibapha</i> subsp. <i>javanica</i> (Amanitaceae) is an edible Korean wild mushroom. <i>A. hemibapha</i> subsp. <i>javanica</i> is often confused with <i>A. subjunquillea</i>, known as the East Asian death cap, which is potentia...

Full description

Saved in:
Bibliographic Details
Main Authors: Seulah Lee (Author), Akida Alishir (Author), Tae Wan Kim (Author), Dong-Min Kang (Author), Rhim Ryoo (Author), Changhyun Pang (Author), Mi-Jeong Ahn (Author), Ki Hyun Kim (Author)
Format: Book
Published: MDPI AG, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c3548d4d6c1c4f6da35c5d9d4667c1a8
042 |a dc 
100 1 0 |a Seulah Lee  |e author 
700 1 0 |a Akida Alishir  |e author 
700 1 0 |a Tae Wan Kim  |e author 
700 1 0 |a Dong-Min Kang  |e author 
700 1 0 |a Rhim Ryoo  |e author 
700 1 0 |a Changhyun Pang  |e author 
700 1 0 |a Mi-Jeong Ahn  |e author 
700 1 0 |a Ki Hyun Kim  |e author 
245 0 0 |a First Chemical Investigation of Korean Wild Mushroom, <i>Amanita hemibapha</i> subsp. <i>javanica</i> and the Identification of Anti-<i>Helicobacter pylori</i> Compounds 
260 |b MDPI AG,   |c 2022-01-01T00:00:00Z. 
500 |a 10.3390/ph15020152 
500 |a 1424-8247 
520 |a <i>Amanita hemibapha</i> subsp. <i>javanica</i> (Amanitaceae) is an edible Korean wild mushroom. <i>A. hemibapha</i> subsp. <i>javanica</i> is often confused with <i>A. subjunquillea</i>, known as the East Asian death cap, which is potentially fatal when ingested. This study aimed to conduct the first chemical investigation of <i>A. hemibapha</i> subsp. <i>javanica</i>, which resulted in the isolation of seven fatty acid derivatives (<b>1</b>-<b>7</b>) and three steroids (<b>8</b>-<b>10</b>) from the MeOH extract of its fruiting bodies, and their structures were determined by comparing their NMR spectroscopic data with those previously reported, along with the data from LC/MS. Compound <b>1</b> was reported previously without the identification of its absolute configuration; its structure, including the absolute configuration was confirmed for the first time, in this study, by using <sup>1</sup>H NMR and its fragmentation patterns in MS/MS data, and LC/MS analysis. A recently developed method using competing enantioselective acylation (CEA) coupled with LC/MS analysis was applied for determining the absolute configuration of compound <b>1</b>, which revealed the 11<i>S</i>-configuration. In the anti-<i>Helicobacter pylori</i> activity test, compound <b>3</b> showed antibacterial activity against <i>H. pylori</i> strain 51 with 38.0% inhibition, comparable to that of quercetin (34.4% inhibition) as a positive control. Specifically, compound <b>4</b> displayed the most potent antibacterial activity against <i>H. pylori</i> strain 51 with 80.5% inhibition at the final concentration of 100 μm with a MIC<sub>50</sub> value of 72 μm. These findings suggested that the active compound <b>4</b> is a natural antibiotic that may be used in the development of novel antibiotics against <i>H. pylori.</i> In addition, the first chemical investigation of <i>A. hemibapha</i> subsp. <i>javanica</i> revealed that this mushroom can serve as a promising natural source for the bioactive natural products. 
546 |a EN 
690 |a <i>Amanita hemibapha</i> subsp. <i>javanica</i> 
690 |a Amanitaceae 
690 |a fatty acid derivatives 
690 |a steroids 
690 |a LC/MS analysis 
690 |a CEA 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 15, Iss 2, p 152 (2022) 
787 0 |n https://www.mdpi.com/1424-8247/15/2/152 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/c3548d4d6c1c4f6da35c5d9d4667c1a8  |z Connect to this object online.